Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
162.34%
operating margin TTM
-228.28%
revenue TTM
1.02 Million
revenue per share TTM
0.3$
valuation ratios | |
|---|---|
| pe ratio | 0.02 |
| peg ratio | 0.00 |
| price to book ratio | -0.03 |
| price to sales ratio | 0.03 |
| enterprise value multiple | 1.12 |
| price fair value | -0.03 |
profitability ratios | |
|---|---|
| gross profit margin | 99.66% |
| operating profit margin | -228.28% |
| pretax profit margin | 162.34% |
| net profit margin | 162.34% |
| return on assets | 70.2% |
| return on equity | -237.65% |
| return on capital employed | 293.26% |
liquidity ratio | |
|---|---|
| current ratio | 0.66 |
| quick ratio | 0.66 |
| cash ratio | 0.63 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 87,998.18 |
| cash conversion cycle | -87,998.18 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -10.45 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.06 |
| cash per share | 2.08 |
| operating cash flow per share | 3.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) reported earnings?
TRACON Pharmaceuticals, Inc. (TCON) published its most recent earnings results on 13-08-2024.
What is TRACON Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s trailing twelve months ROE is -237.65%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. TRACON Pharmaceuticals, Inc. (TCON) currently has a ROA of 70.2%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TCON's net profit margin stand at?
TCON reported a profit margin of 162.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TCON's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.66 in the most recent quarter. The quick ratio stood at 0.66, with a Debt/Eq ratio of 0.00.